CCL2 and colon carcinoma: However, MAT explants obtained from Crohn's disease patients had a significant higher level of expression of inflammatory mediators (IL-6, MCP-1) and leptin and adiponectin when compared to MAT obtained from patients with colon carcinomas (Figure 6, panel 1; n = 5; # p<0.05).